Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/SPEXIS-AG-43371335/news/Spexis-CXCR4-Inhibitor-Balixafortide-zeigt-synergistische-Wirksamkeit-in-40915627/?utm_source=whatsapp&utm_medium=social&utm_campaign=share